Astera Labs (ALAB) COO logs automatic sell-to-cover stock sales after RSU vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Astera Labs, Inc. President and COO Gajendra Sanjay reported automatic tax-related share sales. On 2026-05-18, Form 4 shows the sale of 95,444 shares of Astera Labs common stock in multiple open-market transactions at prices between $216.10 and $235.94 per share.
According to a footnote, these sales were required to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units and were executed under a pre-arranged “sell to cover” election, rather than as discretionary trades. Additional entries show large indirect holdings in three estate planning trusts, for which Sanjay disclaims beneficial ownership except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 95,444 shares ($21,476,949)
Net Sell
20 txns
Insider
Gajendra Sanjay
Role
President and COO
Sold
95,444 shs ($21.48M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 19,404 | $235.4142 | $4.57M |
| Sale | Common Stock | 2,282 | $233.1822 | $532K |
| Sale | Common Stock | 1,946 | $232.8086 | $453K |
| Sale | Common Stock | 7,643 | $231.314 | $1.77M |
| Sale | Common Stock | 3,546 | $230.2794 | $817K |
| Sale | Common Stock | 1,033 | $229.5467 | $237K |
| Sale | Common Stock | 6,196 | $226.641 | $1.40M |
| Sale | Common Stock | 1,629 | $225.274 | $367K |
| Sale | Common Stock | 2,734 | $223.9619 | $612K |
| Sale | Common Stock | 2,464 | $223.3442 | $550K |
| Sale | Common Stock | 19 | $222.52 | $4K |
| Sale | Common Stock | 3,568 | $222.1061 | $792K |
| Sale | Common Stock | 6,924 | $220.6155 | $1.53M |
| Sale | Common Stock | 3,725 | $219.5089 | $818K |
| Sale | Common Stock | 9,409 | $218.4958 | $2.06M |
| Sale | Common Stock | 10,819 | $217.2794 | $2.35M |
| Sale | Common Stock | 12,103 | $216.4604 | $2.62M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,511,897 shares (Direct, null);
Common Stock — 5,664,213 shares (Indirect, By Trust 1)
Footnotes (1)
- Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $235.9400 to $235.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $233.9800 to $233.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $232.9700 to $232.7700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $231.9000 to $230.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $230.7900 to $229.9400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $229.7900 to $228.9350, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $227.0900 to $226.1800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $225.7600 to $225.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $224.5400 to $223.9000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $223.5300 to $222.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $222.5000 to $221.5200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $221.0300 to $220.0800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $220.0000 to $219.0300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $218.8900 to $218.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $217.8900 to $216.9000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $216.8900 to $216.1000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Key Figures
Shares sold: 95,444 shares
Sale price range: $216.10–$235.94 per share
Trust 1 indirect holding: 5,664,213 shares
+2 more
5 metrics
Shares sold
95,444 shares
Total common stock sold on May 18, 2026 for tax withholding
Sale price range
$216.10–$235.94 per share
Weighted-average price ranges across multiple sale tranches
Trust 1 indirect holding
5,664,213 shares
Common stock held by estate planning Trust 1; beneficial ownership disclaimed except pecuniary interest
Trust 2 indirect holding
655,000 shares
Common stock held by estate planning Trust 2; beneficial ownership disclaimed except pecuniary interest
Trust 3 indirect holding
655,000 shares
Common stock held by estate planning Trust 3; beneficial ownership disclaimed except pecuniary interest
Key Terms
restricted stock units, sell to cover, weighted average price, estate planning trust, +1 more
5 terms
restricted stock units financial
"in connection with the vesting and settlement of restricted stock
units previously granted to the Reporting Person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
sell to cover financial
"tax withholding
obligations to be funded by a "sell to cover""
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
estate planning trust financial
"These shares are owned directly by an estate planning trust ("Trust 1")"
pecuniary interest financial
"disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein"
FAQ
What did Astera Labs (ALAB) President and COO Gajendra Sanjay report on this Form 4?
He reported automatic open-market sales of Astera Labs common stock tied to tax withholding. The filing shows 95,444 shares sold on May 18, 2026, in multiple trades, with proceeds used to cover taxes on vesting restricted stock units previously granted as compensation.
What role do restricted stock units play in this Astera Labs (ALAB) Form 4?
The sales stem from the vesting and settlement of restricted stock units previously granted to Gajendra Sanjay. When these RSUs vested, Astera Labs required that tax withholding obligations be funded by selling shares, triggering the automatic “sell to cover” transactions reported in this Form 4.
What indirect Astera Labs (ALAB) holdings are disclosed through estate planning trusts?
The Form 4 lists sizable indirect positions held by three estate planning trusts labeled Trust 1, Trust 2, and Trust 3. Each trust directly owns Astera Labs common stock, and Sanjay disclaims beneficial ownership except to the extent of any pecuniary interest he may have in those trusts.
Does this Astera Labs (ALAB) Form 4 indicate any remaining trust or direct holdings?
Yes. The filing includes holding entries for three estate planning trusts with significant share counts and shows that, after the reported tax-related sales, a substantial direct share position remains. These details outline the broader equity exposure associated with Gajendra Sanjay and related trusts.